Health and beauty

Digital Health: Doctolib Italia acquires Appocrate – Quotidiano Sanità

Doctolib strengthens its presence on the Italian digital health market with the acquisition of Appocrate, an Italian company that designs and implements digital solutions in the relationship between citizens and healthcare facilities.

27 GEN – The Italian-French tech company Doctolib Italia continues its development plan in the Italian market with the acquisition of Appocrate, an Italian company that designs and implements digital solutions in the relationship between citizens and healthcare facilities, thanks to strong skills in the technological field and the design of customized solutions.

In the wake of the international experience that includes support for hundreds of thousands of French and German medical practices and hospitals – including, since 2016, the collaboration with AP-HP (Assistance Publique des Hôpitaux de Paris), the largest university hospital group in Paris. Europe -, Doctolib continues its growth also in Italy, favoring the further development of hospital services.

In the countries where it is present, Doctolib has in fact ensured the optimization of activities in hospital centers, maximizing their efficiency and allowing greater satisfaction among patients. In Italy, where more than two thirds of specialist visits are managed by over 1000 public and private health facilities, Appocrate’s activity becomes essential, as it facilitates patient access to health care and allows hospital staff to concentrate more on patients, with a consequent improvement of the path before and after the visits.

Appocrate was born in 2013 with the aim of reducing the distance between citizens and the world of health, improving the efficiency of health services thanks to the advantages offered by technology. The company created Booking in 2015, for which it also won the Digital Innovation Award in Health, which in addition to the direct booking of the service, also includes acceptance, online payment, the ability to download reports digitally and numerous other important services. Appocrate has also developed solutions to support the COVID emergency in use, among others, at the ASST of the Civil Hospital of Brescia.

This platform is able to interface directly with the management systems of each health facility, exposing to the public the availability and prices of the exams, under the NHS, private, subsidized or insured via web, app and totem.

A multi-service project – in use at hospitals such as the Poliambulanza Foundation in Brescia, the Gemelli Polyclinic, the Fatebenefratelli Isola Tiberina in Rome, the Italian Diagnostic Center in Milan and the F. Miulli Regional General Hospital in Acquaviva delle Fonti in the province of Bari – which is aimed at improving organizational processes and booking procedures.

“We share the same culture and the same mission as Doctolib: people’s health and well-being are the horizon of Appocrate’s projects, in which technology is the means for achieving greater efficiency. To date we collaborate with 45 healthcare facilities in Italy and have managed over 1 million bookings through our Booking platform which already has 550,000 registered users, important numbers that we plan to further expand thanks to Doctolib’s growth strategy “he comments Michele MalteseCo-founder and CEO of Appocrate.

Appocrate will keep its headquarters and its team of resources and thanks to the organization of Doctolib it will be able to accelerate the dissemination of the Booking product to all potential users, offering citizens an additional channel of access to be able to use the services made available by health facilities .

“With the acquisition of Appocrate, Doctolib consolidates its position in the Italian market by strengthening its range of services also within hospitals, to improve the daily life of healthcare personnel and make access to healthcare faster and fairer for all . The agreement reached will also allow Doctolib to further accelerate its presence in most Italian cities ”he declares Nicola Brandolese, CEO of Doctolib Italia.

January 27, 2022
© All rights reserved

Other articles in Science and Drugs







Leave a Reply

Your email address will not be published.